[1] Xian G S,He Z Z,Yan X Y, et al.Correlation study of CYP2C19 gene polymorphism and clopidogrel resistance in Han Chinese patients with cerebral infarction in Guizhou region[J].Medicine,2021,100(6):e24481-e24481.
[2] Lian Y,Xin X.The Relationship Between Clopidogrel Gene Polymorphism to Progressive Stroke or Recurrence[J].International Journal of Neurologic Physical Therapy,2020,6(1):1-6.
[3] 郑剑钧,赵超,陈志伟.阿加曲班联合阿司匹林、氯吡格雷治疗进展型脑梗死患者临床疗效[J].天津药学,2023,35(5):22-26.
[4] 施金婵,张豪,宋昌军.阿司匹林联合硫酸氢氯吡格雷治疗老年急性脑梗死临床疗效及对患者血清炎性因子的影响研究[J].贵州医药,2023,47(12):1873-1874.
[5] 陆丹.阿司匹林联合硫酸氢氯吡格雷治疗脑梗死的效果观察[J].中西医结合心血管病电子杂志,2022,10(26):71-73+67.
[6] 葛均波,徐永健,王辰主编.内科学[M].9版.北京:人民卫生出版社,2018:79-80.
[7] Juan G,Jue W,Yanxia G, et al.Association of aspirin resistance with 4-hydroxynonenal and its impact on recurrent cerebral infarction in patients with acute cerebral infarction.[J].Brain and behavior,2020,10(3):e01562.
[8] WiSun R,Dawid S,KeunSik H, et al.Relation of Pre-stroke Aspirin Use With Cerebral Infarct Volume and Functional Outcomes.[J].Annals of neurology,2021,90(5):763-776.
[9] 陈亚珠,侯玉琳,聂小萍.硫酸氢氯吡格雷联合阿托伐他汀及阿司匹林治疗急性脑梗死的疗效及安全性[J].临床合理用药,2023,16(27):67-70.
[10] 唐欢,潘成永,陈继锋,等.丁苯酞氯化钠联合阿司匹林和氯吡格雷治疗急性脑梗死的效果观察[J].中国处方药,2023,21(8):115-118.
[11] 魏清源,赖巧丽.硫酸氢氯吡格雷联合阿司匹林和阿托伐他汀用于急性脑梗死治疗的疗效观察[J].现代诊断与治疗,2023,34(15):2254-2256.
[12] 赵建彬,赵玮康.双负荷剂量氯吡格雷联合阿司匹林治疗急性脑梗死的疗效研究[J].中国合理用药探索,2023,20(9):73-77. |
